Clinical Trial Update: Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept [Phase 2]

View source ↗

Summary

Phase 2 study completed to evaluate the short-term effects of PRX-03140 in patients with mild Alzheimer's disease who were also taking Aricept.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Aricept (Donepezil)
• PRX-03140

Snippet

Sponsor: Epix Pharmaceuticals, Inc. | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED